Scavenger Receptor BI Boosts Hepatocyte Permissiveness to Plasmodium Infection

Cell Host and Microbe

Volumn 4, Issue 3, 2008, Pages 283-292

  Yalaoui, Samir ^a,b   Huby, Thierry ^a,b   Franetich, Jean François ^a,b   Gego, Audrey ^a,b   Rametti, Armelle ^a,b   Moreau, Martine ^a,b   Collet, Xavier ^b,c   Siau, Anthony ^a,b   van Gemert, Geert Jan ^d   Sauerwein, Robert W ^d   Luty, Adrian J F ^d   Vaillant, Jean Christophe ^e   Hannoun, Laurent ^e   Chapman, John ^a,b   Mazier, Dominique ^a,b,f   Froissard, Patrick ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c France   (France)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CELLBIO; MICROBIO

Indexed keywords

CD81 ANTIGEN; FATTY ACID BINDING PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR BI; TETRASPANIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; HEPATITIS; HEPATITIS C VIRUS; HOST PARASITE INTERACTION; INFECTION SENSITIVITY; LIVER CELL; MALARIA; MALE; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PREDICTION; PRIORITY JOURNAL; SPOROZOITE; STRAIN DIFFERENCE; TRANSGENICS; UPREGULATION;

ANIMALS; ANTIGENS, CD; CELLS, CULTURED; CHOLESTEROL; FEMALE; HEPATOCYTES; HOST-PARASITE INTERACTIONS; HUMANS; LIVER DISEASES; MALARIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMODIUM; SCAVENGER RECEPTORS, CLASS B; SCHIZONTS; SPOROZOITES;

HEPATITIS C VIRUS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII;

EID: 50849107688     PISSN: 19313128     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chom.2008.07.013     Document Type: Article

References (43)

1. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., and Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 (1996) 518-520
2. Agnello V., Abel G., Elfahal M., Knight G.B., and Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 96 (1999) 12766-12771
3. Bano N., Romano J.D., Jayabalasingham B., and Coppens I. Cellular interactions of Plasmodium liver stage with its host mammalian cell. Int. J. Parasitol. 37 (2007) 1329-1341
4. Barth H., Schafer C., Adah M.I., Zhang F., Linhardt R.J., Toyoda H., Kinoshita-Toyoda A., Toida T., Van Kuppevelt T.H., Depla E., et al. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278 (2003) 41003-41012
5. Bartosch B., Vitelli A., Granier C., Goujon C., Dubuisson J., Pascale S., Scarselli E., Cortese R., Nicosia A., and Cosset F.L. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278 (2003) 41624-41630
6. Bietrix F., Yan D., Nauze M., Rolland C., Bertrand-Michel J., Comera C., Schaak S., Barbaras R., Groen A.K., Perret B., et al. Accelerated lipid absorption in mice overexpressing intestinal SR-BI. J. Biol. Chem. 281 (2006) 7214-7219
7. Carraz M., Jossang A., Franetich J.F., Siau A., Ciceron L., Hannoun L., Sauerwein R., Frappier F., Rasoanaivo P., Snounou G., and Mazier D. A plant-derived morphinan as a novel lead compound active against malaria liver stages. PLoS Med. 3 (2006) e513
8. Catanese M.T., Graziani R., von Hahn T., Moreau M., Huby T., Paonessa G., Santini C., Luzzago A., Rice C.M., Cortese R., et al. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J. Virol. 81 (2007) 8063-8071
9. Coppens I., Sinai A.P., and Joiner K.A. Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J. Cell Biol. 149 (2000) 167-180
10. Cunha-Rodrigues M., Portugal S., Febbraio M., and Mota M.M. Infection by and protective immune responses against Plasmodium berghei ANKA are not affected in macrophage scavenger receptors A deficient mice. BMC Microbiol. 6 (2006) 73
11. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Wolk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., and Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446 (2007) 801-805
12. Gego A., Silvie O., Franetich J.F., Farhati K., Hannoun L., Luty A.J., Sauerwein R.W., Boucheix C., Rubinstein E., and Mazier D. New approach for high-throughput screening of drug activity on Plasmodium liver stages. Antimicrob. Agents Chemother. 50 (2006) 1586-1589
13. Grove J., Huby T., Stamataki Z., Vanwolleghem T., Meuleman P., Farquhar M., Schwarz A., Moreau M., Owen J.S., Leroux-Roels G., et al. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J. Virol. 81 (2007) 3162-3169
14. Hubbard A.L., Wall D.A., and Ma A. Isolation of rat hepatocyte plasma membranes. I. Presence of the three major domains. J. Cell Biol. 96 (1983) 217-229
15. Huby T., Doucet C., Dachet C., Ouzilleau B., Ueda Y., Afzal V., Rubin E., Chapman M.J., and Lesnik P. Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues. J. Clin. Invest. 116 (2006) 2767-2776
16. Kapadia S.B., Barth H., Baumert T., McKeating J.A., and Chisari F.V. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 81 (2007) 374-383
17. Maillard P., Huby T., Andreo U., Moreau M., Chapman J., and Budkowska A. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. FASEB J. 20 (2006) 735-737
18. Marshall P., Rohlmann A., Nussenzweig V., Herz J., and Sinnis P. Plasmodium sporozoites invade cells with targeted deletions in the LDL receptor related protein. Mol. Biochem. Parasitol. 106 (2000) 293-298
19. Mikolajczak S.A., Jacobs-Lorena V., MacKellar D.C., Camargo N., and Kappe S.H. L-FABP is a critical host factor for successful malaria liver stage development. Int. J. Parasitol. 37 (2007) 483-489
20. Muller H.M., Reckmann I., Hollingdale M.R., Bujard H., Robson K.J., and Crisanti A. Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J. 12 (1993) 2881-2889
21. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., and Abrignani S. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
22. Prudencio M., Rodriguez A., and Mota M.M. The silent path to thousands of merozoites: The Plasmodium liver stage. Nat. Rev. Microbiol. 4 (2006) 849-856
23. Renia L., Mattei D., Goma J., Pied S., Dubois P., Miltgen F., Nussler A., Matile H., Menegaux F., Gentilini M., and Mazier D. A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur. J. Immunol. 20 (1990) 1445-1449
24. Renia L., Miltgen F., Charoenvit Y., Ponnudurai T., Verhave J.P., Collins W.E., and Mazier D. Malaria sporozoite penetration. A new approach by double staining. J. Immunol. Methods 112 (1988) 201-205
25. Rhainds D., Bourgeois P., Bourret G., Huard K., Falstrault L., and Brissette L. Localization and regulation of SR-BI in membrane rafts of HepG2 cells. J. Cell Sci. 117 (2004) 3095-3105
26. Rhainds D., and Brissette L. The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders. Int. J. Biochem. Cell Biol. 36 (2004) 39-77
27. Rhainds D., Brodeur M., Lapointe J., Charpentier D., Falstrault L., and Brissette L. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters. Biochemistry 42 (2003) 7527-7538
28. Rubinstein E., Le Naour F., Lagaudriere-Gesbert C., Billard M., Conjeaud H., and Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26 (1996) 2657-2665
29. Scarselli E., Ansuini H., Cerino R., Roccasecca R.M., Acali S., Filocamo G., Traboni C., Nicosia A., Cortese R., and Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21 (2002) 5017-5025
30. Seveau S., Bierne H., Giroux S., Prevost M.C., and Cossart P. Role of lipid rafts in E-cadherin-and HGF-R/Met-mediated entry of Listeria monocytogenes into host cells. J. Cell Biol. 166 (2004) 743-753
31. Silvie O., Charrin S., Billard M., Franetich J.F., Clark K.L., van Gemert G.J., Sauerwein R.W., Dautry F., Boucheix C., Mazier D., and Rubinstein E. Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites. J. Cell Sci. 119 (2006) 1992-2002
32. Silvie O., Franetich J.F., Boucheix C., Rubinstein E., and Mazier D. Alternative invasion pathways for Plasmodium berghei sporozoites. Int. J. Parasitol. 37 (2007) 173-182
33. Silvie O., Greco C., Franetich J.F., Dubart-Kupperschmitt A., Hannoun L., van Gemert G.J., Sauerwein R.W., Levy S., Boucheix C., Rubinstein E., and Mazier D. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species. Cell. Microbiol. 8 (2006) 1134-1146
34. Silvie O., Rubinstein E., Franetich J.F., Prenant M., Belnoue E., Renia L., Hannoun L., Eling W., Levy S., Boucheix C., and Mazier D. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat. Med. 9 (2003) 93-96
35. Sinnis P., and Febbraio M. Plasmodium yoelii sporozoites infect CD36-deficient mice. Exp. Parasitol. 100 (2002) 12-16
36. Sinnis P., Willnow T.E., Briones M.R., Herz J., and Nussenzweig V. Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. J. Exp. Med. 184 (1996) 945-954
37. Sturm A., Amino R., van de Sand C., Regen T., Retzlaff S., Rennenberg A., Krueger A., Pollok J.M., Menard R., and Heussler V.T. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313 (2006) 1287-1290
38. Truong T.Q., Auger A., Denizeau F., and Brissette L. Analysis of low-density lipoprotein catabolism by primary cultures of hepatic cells from normal and low-density lipoprotein receptor knockout mice. Biochim. Biophys. Acta 1484 (2000) 307-315
39. Voisset C., Callens N., Blanchard E., Op De Beeck A., Dubuisson J., and Vu-Dac N. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J. Biol. Chem. 280 (2005) 7793-7799
40. Voisset C., Lavie M., Helle F., Op De Beeck A., Bilheu A., Bertrand-Michel J., Terce F., Cocquerel L., Wychowski C., Vu-Dac N., and Dubuisson J. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. Cell. Microbiol. 10 (2008) 606-617
41. Witney A.A., Doolan D.L., Anthony R.M., Weiss W.R., Hoffman S.L., and Carucci D.J. Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy. Mol. Biochem. Parasitol. 118 (2001) 233-245
42. Yalaoui S., Zougbédé S., Charrin S., Silvie O., Arduise C., Khemais F., Boucheix C., Mazier D., Rubinstein E., and Froissard P. Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain. PLoS Pathog. 4 (2008) e1000010
43. Zhang J., Randall G., Higginbottom A., Monk P., Rice C.M., and McKeating J.A. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 78 (2004) 1448-1455